171 results
Page 6 of 9
8-K
EX-10.2
i07xx v6qqtazw
27 Jun 19
Departure of Directors or Certain Officers
8:08am
8-K
EX-99.1
9auer
6 May 19
Adaptimmune TRANSFORMING T CELL THERAPY Clinical and Business Update
8:11am
8-K
EX-99.1
jx1i6tb6zapm
6 May 19
Significant Clinical Progress as Adaptimmune Announces Responses with ADP-A2M4 in Synovial Sarcoma and Antitumor Activity in Other Solid Tumors
7:08am
8-K/A
EX-99.1
5knyo79n vlrqhuxymtq
27 Feb 19
CORRECTING and REPLACING — Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
5:16pm
8-K
EX-99.1
00fbtznx
27 Feb 19
Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
7:43am
8-K
EX-99.1
6wekudb89 dj65
2 Aug 18
Adaptimmune Reports Second Quarter 2018 Financial Results and Business Update
7:41am
S-3ASR
hw21wfeo
12 Jul 18
Automatic shelf registration
4:30pm
S-3ASR
EX-23.2
s4qc99jb
12 Jul 18
Automatic shelf registration
4:30pm
8-K
EX-99.1
iu3zkn33p0ilng44ym
6 Jul 18
Departure of Directors or Certain Officers
5:00pm
8-K
x6a2s3g8h7n
6 Jul 18
Departure of Directors or Certain Officers
5:00pm
8-K
EX-99.1
fymalqo
9 May 18
Adaptimmune Reports First Quarter 2018 Financial Results and Business Update
7:39am